Organon & Co
NYSE:OGN
Organon & Co
Change in Deffered Taxes
Organon & Co
Change in Deffered Taxes Peer Comparison
Competitive Change in Deffered Taxes Analysis
Latest Figures & CAGR of Competitors
Company | Change in Deffered Taxes | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Organon & Co
NYSE:OGN
|
Change in Deffered Taxes
-$485m
|
CAGR 3-Years
-147%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Change in Deffered Taxes
-$4.2B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-24%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Change in Deffered Taxes
-$3.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-117%
|
CAGR 10-Years
-33%
|
|
Pfizer Inc
NYSE:PFE
|
Change in Deffered Taxes
-$3.3B
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
Change in Deffered Taxes
-$1.7B
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
-12%
|
|
Eli Lilly and Co
NYSE:LLY
|
Change in Deffered Taxes
-$2.1B
|
CAGR 3-Years
-98%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Organon & Co's Change in Deffered Taxes?
Change in Deffered Taxes
-485m
USD
Based on the financial report for Dec 31, 2023, Organon & Co's Change in Deffered Taxes amounts to -485m USD.
What is Organon & Co's Change in Deffered Taxes growth rate?
Change in Deffered Taxes CAGR 3Y
-147%
Over the last year, the Change in Deffered Taxes growth was -2 594%. The average annual Change in Deffered Taxes growth rates for Organon & Co have been -147% over the past three years .